Targeted UVB phototherapy for psoriasis: A preliminary study

M. Lapidoth*, M. Adatto, M. David

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Excimer laser treatment for psoriasis has been associated with good results at a lower cumulative dose than narrowband ultraviolet (UV)B protocols. To examine the clinical performance of a new targeted UVB lamp (290-320 nm; BClear™) in the treatment of plaque-type psoriasis, 28 consecutive patients attending a dermatology service were treated twice weekly with the UVB lamp for 6-18 sessions (median 10). UV doses were based on multiples of a predetermined minimal erythema dose (MED). MEDs ranged from 150 to 350 mJ/cm2; maximal dose was 8 MED. Mean cumulative fluence until remission was 12.63 J/cm2. The Psoriasis Severity Index (PSI) was measured every 2 weeks for 16 weeks. Mean PSI improvement during treatment peaked at 73% after 6 weeks, and declined to 63% at 16 weeks. At that point, 36% of the patients had a >75% improvement in PSI, and 21% showed complete clearance. Targeted radiation with the UVB lamp is effective for the treatment of plaque-type psoriasis, requiring as few as six sessions and achieving moderately long remission. As treatment is selectively directed toward lesioned skin, normal surrounding skin is spared unnecessary radiation exposure.

Original languageEnglish
Pages (from-to)642-645
Number of pages4
JournalClinical and Experimental Dermatology
Issue number6
StatePublished - Nov 2007


Dive into the research topics of 'Targeted UVB phototherapy for psoriasis: A preliminary study'. Together they form a unique fingerprint.

Cite this